Ver­tan­i­cal’s Phase 3 win for non-opi­oid painkiller; Apri­ori lays off 40% of staff 

Plus, news about Pil­lar, vTv Ther­a­peu­tics, OP­KO Health, En­tera Bio, Zen­tal­is, Sutro Bio­phar­ma and Idor­sia:

Ver­tan­i­cal’s non-opi­oid painkiller suc­ceeds in Phase 3: The Ger­man biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER